Human placenta-derived mesenchymal stromal cells transfusion in a critically Ill infant diagnosed with Coronavirus Disease 2019 (COVID-19): A case report

Coronavirus disease 2019 (COVID-19) is still an emergency in many countries. Herein, we report treatment with human placental-derived mesenchymal stromal cells transfusion (hPD-MSCT) in a critically ill infant diagnosed with COVID-19. A 28-day-old male infant with a history of pneumonia was referred...

Descripción completa

Detalles Bibliográficos
Autores principales: Payandeh, Mehrdad, Habibi, Reza, Norooznezhad, Amir Hossein, Hoseinkhani, Zohreh, Mansouri, Feizollah, Yarani, Reza, Thakor, Avnesh S., Bakhtiari, Mitra, Esmailli, Farzaneh, Mansouri, Kamran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085352/
https://www.ncbi.nlm.nih.gov/pubmed/35618640
http://dx.doi.org/10.1016/j.transci.2022.103454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085352/
https://www.ncbi.nlm.nih.gov/pubmed/35618640
http://dx.doi.org/10.1016/j.transci.2022.103454

Ejemplares similares